A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/135 (2006.01) A61K 9/20 (2006.01) A61K 9/22 (2006.01) A61K 47/18 (2006.01) A61K 47/38 (2006.01)
Patent
CA 2142320
A controlled sustained release tablet having at least one year shelf life and containing bupropion hydrochloride, hydroxyp- ropyl methylcellulose and cysteine hydrochloride or glycine hydrochloride with the tablet having a surface area to volume ratio to effectively control bupropion hydrochloride release in the body.
Bass William Leroy Jr.
Ludwig Jennie Sue Galloway
Sutton Joel Elmore Jr.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Biovail Laboratories International Srl
The Wellcome Foundation Limited
LandOfFree
Sustained release tablets containing bupropion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained release tablets containing bupropion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release tablets containing bupropion will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1707705